J
Jarkko Soronen
Researcher at National Institutes of Health
Publications - 17
Citations - 705
Jarkko Soronen is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Adipose tissue & Insulin. The author has an hindex of 12, co-authored 16 publications receiving 632 citations. Previous affiliations of Jarkko Soronen include Bayer & Minerva Foundation Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
Maija Bry,Riikka Kivelä,Tanja Holopainen,Andrey Anisimov,Tuomas Tammela,Jarkko Soronen,Johanna M. U. Silvola,Antti Saraste,Michael Jeltsch,Petra Korpisalo,Peter Carmeliet,Karl B. Lemström,Masabumi Shibuya,Seppo Ylä-Herttuala,Leena Alhonen,Eero Mervaala,Leif C. Andersson,Juhani Knuuti,Kari Alitalo +18 more
TL;DR: In rats, the heart-specific VEGF-B transgene induced impressive growth of the epicardial coronary vessels and their branches, with large arteries also seen deep inside the subendocardial myocardium, however, VEGf-B, unlike other V EGF family members, did not induce significant capillary angiogenesis, increased permeability, or inflammatory cell recruitment.
Journal ArticleDOI
Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
Andrey Anisimov,Annamari Alitalo,Petra Korpisalo,Jarkko Soronen,Seppo Kaijalainen,Veli-Matti Leppänen,Michael Jeltsch,Seppo Ylä-Herttuala,Kari Alitalo +8 more
TL;DR: It is concluded that long-term expression of VEGF-C and V EGF-D in skeletal muscle results in the generation of new functional blood and lymphatic vessels.
Journal ArticleDOI
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
P.A. Nidhina Haridas,Jarkko Soronen,Jarkko Soronen,Sanja Sädevirta,Sanja Sädevirta,Raghavendra Mysore,Fabiana Quagliarini,Arja Pasternack,Jari Metso,Julia Perttilä,Marja Leivonen,Cynthia M. Smas,Pamela Fischer-Posovszky,Martin Wabitsch,Christian Ehnholm,Olli Ritvos,Matti Jauhiainen,Vesa M. Olkkonen,Hannele Yki-Järvinen +18 more
TL;DR: Overexpression of ANGPTL8 in CHO cells did not result in its release into culture medium while abundant secretion occurred in cells co-expressing AngPTL3 and -8, and measurement of plasma ANGPTl3 but not -8 reflects insulin action in target tissues.
Journal ArticleDOI
Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects
Jarkko Soronen,Jarkko Soronen,Pirkka-Pekka Laurila,Pirkka-Pekka Laurila,Jussi Naukkarinen,Jussi Naukkarinen,Ida Surakka,Ida Surakka,Samuli Ripatti,Samuli Ripatti,Matti Jauhiainen,Matti Jauhiainen,Vesa M. Olkkonen,Hannele Yki-Järvinen +13 more
TL;DR: In this article, the authors compared acute in vivo effects of insulin on adipose tissue transcriptional profiles between obese insulin-resistant and lean insulin-sensitive women and found that the most prominent difference in gene expression of the insulin resistant group during hyperinsulinemia was reduced transcription of nuclear genes involved in mitochondrial respiration (mitochondrial respiratory chain, GO:0001934).
Journal ArticleDOI
USF1 deficiency activates brown adipose tissue and improves cardiometabolic health
Pirkka-Pekka Laurila,Pirkka-Pekka Laurila,Jarkko Soronen,Jarkko Soronen,Sander Kooijman,Saara Forsström,Mariëtte R. Boon,Ida Surakka,Essi Kaiharju,Claudia P. Coomans,Sjoerd A.A. van den Berg,Anu Autio,Antti-Pekka Sarin,Johannes Kettunen,Johannes Kettunen,Emmi Tikkanen,Emmi Tikkanen,Tuula Manninen,Tuula Manninen,Jari Metso,Reija Silvennoinen,Krista Merikanto,Maija Ruuth,Julia Perttilä,Anne M. Mäkelä,Ayaka Isomi,Anita M. Tuomainen,Anna Tikka,Usama Abo Ramadan,Ilkka Seppälä,Terho Lehtimäki,Johan G. Eriksson,Aki S. Havulinna,Antti Jula,Pekka J. Karhunen,Veikko Salomaa,Markus Perola,Christian Ehnholm,Miriam Lee-Rueckert,Miranda Van Eck,Anne Roivainen,Anne Roivainen,Marja-Riitta Taskinen,Leena Peltonen,Eero Mervaala,Anu Jalanko,Esa Hohtola,Vesa M. Olkkonen,Samuli Ripatti,Petri T. Kovanen,Patrick C.N. Rensen,Anu Suomalainen,Anu Suomalainen,Matti Jauhiainen +53 more
TL;DR: By inactivating USF1 in mice, protection against diet-induced dyslipidemia, obesity, insulin resistance, hepatic steatosis, and atherosclerosis is demonstrated and the potential of USf1 as a therapeutic target for cardiometabolic disease is pointed to.